NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 11, 2013

Primary Completion Date

September 8, 2015

Study Completion Date

September 8, 2015

Conditions

Solid TumorsBrain TumorsSarcomaPediatric CancersNeuroblastoma

Interventions

BIOLOGICAL

Recombinant human interleukin-15 (rhIL-15)

Continuous infusion rhIL15 IV

BIOLOGICAL

NK Cell Infusion

Infuse expanded NK cells at Day 0 after 2 days of Cyclophosphamide lymphodepletion

Trial Locations (1)

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT01875601 - NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter